Capital Fund Management (CFM)’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
6CM
ACM
KGAMU
JCM
Capital Fund Management (CFM)'s CDLX Position: Q3 2021 in Review
Capital Fund Management (CFM) sold out of Cardlytics (CDLX) in Q3 2021, closing a stake of 1,361 shares — an estimated $1.38M sold.
Capital Fund Management (CFM) first reported a position in CDLX in Q2 2021 and held it in 1 quarter. The position peaked at $1.73M in Q2 2021. 164 funds tracked by Wall St. Rank hold CDLX as of Q3 2021.
- Capital Fund Management (CFM) reported no remaining Cardlytics position as of Q3 2021 after selling out during the quarter.
- Capital Fund Management (CFM) sold 1,361 Cardlytics shares in Q3 2021, an estimated $1.38M.
- Capital Fund Management (CFM) first reported a position in Cardlytics in Q2 2021 and held it in 1 quarter.
- Capital Fund Management (CFM)'s Cardlytics position peaked at $1.73M in Q2 2021.
- 164 funds tracked by Wall St. Rank held Cardlytics as of Q3 2021.
Based on Capital Fund Management (CFM)'s 13F filing for Q3 2021, filed 12 Nov 2021.